---
figid: PMC6307844__JCMM-23-59-g001
figtitle: Pathways participate in tumourigenesis of CCA
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetus cricetus
- Clonorchis sinensis
- Opisthorchis viverrini
- Cyathopoma iota
- Homo sapiens
- Pleistophora sp. 1
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC6307844
filename: JCMM-23-59-g001.jpg
figlink: /pmc/articles/PMC6307844/figure/jcmm13953-fig-0001/
number: F1
caption: The pathways participate in tumourigenesis of CCA. A, Extracellular WNT glycoproteins
  appear and bind to Frizzled receptors and the co‐receptors LRP5 (low‐density lipoprotein
  receptor‐related protein 5) and LRP6, DVL inhibit the destruction complex that made
  of APC, GSK3β and AXIN and results in the accumulation of β‐catenin in cell cytoplasm.
  β‐catenin enters nucleus and combines with TCF/LEF transcription factors to regulate
  the expression of target genes. Then, influencing the CCA. B, NF‐kB integrates with
  inhibiting factor IkB in the stationary state. After IkBs are phosphorylated by
  IKK or ubiquitnated by SCF‐E3 and degraded by protease, NF‐kB is activated and entering
  nucleus to induce the transcription of target genes. C, DSL family bind to notch
  receptors and stimulate the notch protein shear. And the generated NICD turns into
  nucleus to combine with transcription factor CLS. The compound activates the expression
  of target genes to induce CCA (D) EGFRs combine with EGFR ligands to activate protein
  kinases. Thymidine kinase is phosphorylated to stimulate Ras2/Raf2/MAPK signalling
  pathway, PI3K/AKT pathway and JAK/STAT pathway that play important roles in CCA
  carcinogenesis
papertitle: 'The role of tumour microenvironment: a new vision for cholangiocarcinoma.'
reftext: Ziyan Chen, et al. J Cell Mol Med. 2019 Jan;23(1):59-69.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9630664
figid_alias: PMC6307844__F1
figtype: Figure
redirect_from: /figures/PMC6307844__F1
ndex: 6f33b03b-ded5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6307844__JCMM-23-59-g001.html
  '@type': Dataset
  description: The pathways participate in tumourigenesis of CCA. A, Extracellular
    WNT glycoproteins appear and bind to Frizzled receptors and the co‐receptors LRP5
    (low‐density lipoprotein receptor‐related protein 5) and LRP6, DVL inhibit the
    destruction complex that made of APC, GSK3β and AXIN and results in the accumulation
    of β‐catenin in cell cytoplasm. β‐catenin enters nucleus and combines with TCF/LEF
    transcription factors to regulate the expression of target genes. Then, influencing
    the CCA. B, NF‐kB integrates with inhibiting factor IkB in the stationary state.
    After IkBs are phosphorylated by IKK or ubiquitnated by SCF‐E3 and degraded by
    protease, NF‐kB is activated and entering nucleus to induce the transcription
    of target genes. C, DSL family bind to notch receptors and stimulate the notch
    protein shear. And the generated NICD turns into nucleus to combine with transcription
    factor CLS. The compound activates the expression of target genes to induce CCA
    (D) EGFRs combine with EGFR ligands to activate protein kinases. Thymidine kinase
    is phosphorylated to stimulate Ras2/Raf2/MAPK signalling pathway, PI3K/AKT pathway
    and JAK/STAT pathway that play important roles in CCA carcinogenesis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il10
  - Il6
  - Tnf
  - Apc
  - Axin1
  - Nfkb1
  - Ctnnb1
  - Akt1
  - Notch1
  - Gsk3b
  - Ptpra
  - IL10
  - IL6
  - TNF
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - APC
  - PROC
  - ATP8A2
  - AXIN1
  - AXIN2
  - NFKB1
  - CTNNB1
  - LEF1
  - TCF7
  - TCF7L1
  - TCF7L2
  - HNF4A
  - RPS6KA3
  - CRLS1
  - AKT1
  - AKT2
  - AKT3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - RRBP1
  - HES1
  - HES2
  - HES3
  - HES4
  - HES5
  - HES6
  - HES7
  - GSK3B
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - Dvl1
  - Nfkbib
  - Hps3
  - Apk
  - Ear10
  - Atcay
  - Lrp1
  - Mvp
  - Txlng
  - egr
  - 18w
  - tok
  - tlr-2
  - fz
  - dsh
  - IKKepsilon
  - key
  - IKKbeta
  - Apc2
  - Axn
  - Fs(3)Apc
  - ATPsynbeta
  - Atpalpha
  - Dif
  - dl
  - Rel
  - arm
  - pan
  - CLS
  - Coa
  - Nplp1
  - RAF2
  - Akt
  - .na.character
  - Stat92E
  - Rop
  - Ras64B
  - hop
  - bsk
  - spn-E
  - E(spl)m8-HLH
  - sgg
  - gskt
  - MKP-4
  - p38b
  - rl
  - arr
  - APC
  - ATP
  - Thymidine
  - CLS
---
